Investigation of the Safety and Tolerability of BSCT (Anti-nf-P2X7) 10% Ointment
Status:
Completed
Trial end date:
2014-04-01
Target enrollment:
Participant gender:
Summary
This is a Phase 1, open-label, single-arm, multicenter study to assess the safety and
tolerability of BSCT (anti-nf-P2X7) 10% Ointment in subjects with BCC.